Life Sciences and Transformational Health

  The influenza season is one of the key drivers that is triggering the demand for  flu vaccines . Moreover, the surging number of  COVID-19  patients has created an unprecedented demand for flu vaccines that prevent exposure to the novel virus. Sustained investments will play an instrumental role in the development of tailor-made flu vaccines, according to a new Persistence Market Research (PMR) study. The market value crossed its  US$ 4 Bn  mark in  2018 , says the report. Modernization of manufacturing processes is vital to scale up the production of vaccines and meet growing demands of individuals, owing to the onset of the nearly approaching influenza pandemic. Manufacturers tap opportunities in oral approach to meet convenience of individuals. Universal vaccines emerge as cost efficient solutions for pharmaceutical companies. Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/28720 Companies covered in Flu Vaccine...

 Molecular diagnostics market is growing at a significant rate due to increasing awareness for the same and rising investments in the field. Genetic testing refers to a process of analysis of human DNA in any of its form or related products such as RNA, chromosomes, DNA and others. Genetic testing is widely used for detection of diseases that are related to genotype, phenotype or mutation. Also, genetic testing is done to detect karyotype for clinical purposes. Popularity of genetic testing is increasing due to various advantages offered by this procedure such as detection of genetic abnormalities in early gestation period of about 8 to 10 weeks.  In addition, it also helps to determine the sex the fetus. Genetic testing market is growing at a significant rate due to increasing awareness and discoveries in the field. Of all the tests performed for genetic testing, screening for genetic mutations with Cystic Fibrosis Trans-Membrane Conductance Regulator (CFTR) gene is most wide...

 Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients. Demand for statins is long driven by increasing healthcare awareness among common masses. In U.S., over 500,000 people suffers heart attack every year.  Though cholesterol level is easy to maintain provided one follow healthy diet, sedentary lifestyle has been a major challenge for over last several years. As such, over quarter of the Americans in U.S. take statins to lower down the cholesterol level. Over the past few years, statins market has proved to be a lucrative and profitable market, especially for players that are focused on it. Consumption of statins is quite high among geriatrics population. Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide. As per the WHO, Europe follow...

 Ataxia is a neurological condition, characterized by lack of voluntary coordination of muscle movement. Ataxia causes head trauma, stroke, Transient Ischemic Attack (TIA), tumor and toxic reaction. Progressive ataxia and weakness disorders are related to damage, degeneration or loss of neurons of the brain which leads to muscle coordination disability. The global market for treatments of syndromes of progressive ataxia and weakness disorders is categorized based on various drugs used for treatment of progressive ataxia syndromes, drugs for progressive weakness syndromes and by technology. The progressive ataxia syndrome segment is further sub-segmented into major diseases, such as Friedreich’s ataxia, Gertsman-Straussler-Scheinker disease and Machado-Joseph disease. The progressive weakness syndrome segment includes amyotrophic lateral sclerosis, hereditary spastic paraplegia, hereditary neuropathies, progressive bulbar palsy and multiple sclerosis. The technology segment is furth...

 Biomaterial is any substance or combination other than drugs which may be synthetic or natural in origin. These materials can be used at any period of time which replaces totally or partially any organ, tissue or function of the body to enhance the life of individual as stated by American National Institute of Health. The study of biomaterials is known as biomaterials science, which consists of elements such as biology, medicine, chemistry and tissue engineering among others. Biomaterials either occur naturally or are synthesized in the laboratory by using variety of chemical approaches by using metallic components such as ceramics, polymers or composite materials. They often have medical applications and thus they have the ability to comprise a part or whole of the living structure or biomedical devices. The major drivers for the biomaterials market include increasing aging population, advanced technology, enhanced benefits and rising awareness for biomaterials products. Further ...

 Multiple myeloma is a disorder in malignant plasma cell which mostly affects secondary organs such as bone, renal, bone marrow, immune as well as neurologic dysfunction. Multiple myeloma is a malignancy in clonal plasma cell that results from complex interactions between bone marrow stromal cells, malignant progenitor cells and the bone marrow microenvironment. Refractory multiple myeloma can be defined as a disease that is progressive or non-responsive on therapy or within sixty days of last treatment in patients with less response. According to Janseen report 2016, an estimate of 38,000 new multiple myeloma cases were recorded each year in Europe. In addition to that, 28% multiple myeloma patients die within a year of diagnosis. Refractory multiple myeloma treatment is expected to register significant growth in the market owing to increasing prevalence of multiple myeloma, advancement in research and development for innovative therapeutics for the refractory multiple myeloma tre...

 Multiple myeloma is a disorder in malignant plasma cell which mostly affects secondary organs such as bone, renal, bone marrow, immune as well as neurologic dysfunction. Multiple myeloma is a malignancy in clonal plasma cell that results from complex interactions between bone marrow stromal cells, malignant progenitor cells and the bone marrow microenvironment. Refractory multiple myeloma can be defined as a disease that is progressive or non-responsive on therapy or within sixty days of last treatment in patients with less response. According to Janseen report 2016, an estimate of 38,000 new multiple myeloma cases were recorded each year in Europe. In addition to that, 28% multiple myeloma patients die within a year of diagnosis. Refractory multiple myeloma treatment is expected to register significant growth in the market owing to increasing prevalence of multiple myeloma, advancement in research and development for innovative therapeutics for the refractory multiple myeloma tre...

 A large population is addicted to some kind of illicit drug, opioid is one of the drug class responsible for a greater number abuse and death cases. The recurrent use of opioid can cause chronic brain disorder which ultimately leads to death if not cured or supported well.  Medication-assisted treatment is one of the key treatment plans set by healthcare bodies to end this global problem. Medication-assisted treatment is a combination of approved drug types that are beneficial to end the opioid dependency with counseling and behavioral therapies. It lessens the cravings and withdrawal symptoms of opioid. The global market for medication-assisted treatment has a tremendous value potential. The market value is influenced with the significant number of initiatives held by bodies to end the opioid crisis, WHO is involved in making medication-assisted treatment as a gold standard to assist addicted patients. There are restraining factors present in the market which lowers the adop...

 Oesophagus is the tube like structure which extends from the throat to stomach helping in moving food and other edible things to reach from mouth to stomach. Cancer is one of the leading cause of the death across the world and impregnable nature of late stage cancers of all types due to various impediments such as late stage diagnosis, unavailability of desired treatment options, high cost burden of treatment, etc. further makes it more life threatening. The overall prevalence of all type cancer is on the rise in last decade or so due to various factors such as habits, environment, etc. According to American Cancer Society, around 17,650 new cases of oesophageal cancer diagnosed in the United States in 2017 and around 16,080 deaths occurred in same year due to oesophageal cancer. The lifetime risk of the oesophageal cancer is even more in the United States, i.e. 1 in 132 men and 1 in 455 women which represents significant population at the risk of developing oesophageal cancer. In...

 Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted delivery for onsite drug release and absorption are the basis for the development of advanced drug delivery systems. Furthermore, the development of improved methods of drug delivery is preferred these days over the search for novel molecules. There are various dosage forms available by which a drug substance can be incorporated for efficacious delivery. Advancements in biotechnology and nanotechnology have significantly boosted the development of novel drug delivery approaches. Various interdisciplinary studies in the field of polymer science, pharmaceuticals, organic chemistry and molecular biology are required for the development of advanced drug delivery systems. The drug delivery sys...

Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted delivery for onsite drug release and absorption are the basis for the development of advanced drug delivery systems. Furthermore, the development of improved methods of drug delivery is preferred these days over the search for novel molecules. There are various dosage forms available by which a drug substance can be incorporated for efficacious delivery. Advancements in biotechnology and nanotechnology have significantly boosted the development of novel drug delivery approaches. Various interdisciplinary studies in the field of polymer science, pharmaceuticals, organic chemistry and molecular biology are required for the development of advanced drug delivery systems. The drug delivery system c...

  Increasing prevalence of pressure ulcer and increasing adoption coupled with increasing acquaintance of heel pressure injury relieving devices expected to gain traction throughout the forecast period in the heel pressure injury relieving devices market. According to a latest research by the company, the global heel pressure injury relieving devices market is anticipated to account for over  US$ 529.0 Mn , in terms of value, by  2026  end. The report on heel pressure injury relieving devices further projects significant growth potential through 2026. Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/25048 Company Profiles Stryker Corporation EHOB DeRoyal Industries, Inc. DermaSaverPro Mölnlycke Health Care AB Medline Owens & Minor, Inc. Posey Products, LLC Maxxcare B.V. Skil-Care Corporation Others. Factors Influencing Revenue Growth of the Global Heel Pressure Injury Relieving Devices Market The rapidly increasing ger...

  In a recently published market research study, Persistence Market Research presents a detailed opportunity analysis of the  global anticancer drugs market , revealing key factors likely to have a significant impact on revenue growth of the anticancer drugs market in the next few years. Over the years, there has been an increasing emphasis on R&D in drug development and therapies for the treatment of different types of cancer. Pharmaceutical companies are introducing novel drug formulations in the global market, thereby expanding the product pipeline for cancer treatment. This is likely to create newer vistas of growth in the anticancer drugs market. Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/24355 Company Profiles F. Hoffmann-La Roche Ltd Roche Holding AG Celgene Corp Novartis AG Bristol-Myers Squibb Co Johnson & Johnson Merck & Co. Eli Lilly and Company AstraZeneca plc Amgen Inc.. Get To Know Methodology of Report @ ...

  The pharmaceutical packaging equipment is highly demanded in the market to improve the safety and quality of the packaging of different pharmaceutical products. The reduction in time achieved by these equipment aids the production and innovation in personalized drugs and drug delivery systems. The burgeoning demand for integrated and flexible packaging, the rapid growth of the pharmaceutical sector, and innovations in the drug delivery techniques are some of the prominent growth drivers in the market. Different types of equipment such as equipment from primary packaging and equipment for labeling and sterilization are collectively escalating the revenue in the market. To remain ‘ahead’ of your competitors, request for a sample here@    https://www.persistencemarketresearch.com/samples/3037 North America is estimated to be the largest market for theses equipment followed by Europe and Asia. Different factors such as investments in new techniques, high healthcare exp...